课题基金 / 基金详情

TASK V13: DEEP ANTIBODY PROFILING FOR INFECTION AND VACCINATION

TASK V13: DEEP ANTIBODY PROFILING FOR INFECTION AND VACCINATION
任务 V13：感染和疫苗接种的深度抗体分析
批准号：
10892740
负责人：
THOMAS RUDGE
金额：
$5.66万
依托单位：
BATTELLE CENTERS/PUB HLTH RES & EVALUATN
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
项目状态：
已结题
起止时间：
2022-06-01 至 2024-12-31
来源：
https://reporter.nih.gov/project-details/10892740
关键词：
AntibodiesBiologicalBiological ProductsBioterrorismCommunicable DiseasesContractsDevelopmentEmerging Communicable DiseasesFeasibility StudiesHumanInfectionInvestigational New Drug ApplicationLicensingRespiratory syncytial virusServicesVaccinationVaccinesevaluation/testingnovel vaccinesproduct developmenttesting servicesvaccine candidatevaccine development

项目摘要

项目成果

THOMAS RUDGE的其他基金

相似基金

相关文献

中文摘要
翻译
传染病疫苗和其他生物制品的评估和测试服务（ETS）合同提供了从早期可行性研究到提交生物许可申请（BLA）和/或研究性新药（IND）申请所需的活动的各种产品开发服务。这些服务将促进开发和引进新的候选疫苗和生物制剂（由生物和生物研究中心管制），以对付潜在的生物恐怖主义制剂以及新出现和重新出现的传染病。
英文摘要
The Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of product development services from early feasibility studies through activities required for the submission of Biologic License Application (BLA) and/or Investigational New Drug (IND) applications. These services will facilitate the development and introduction of new vaccine candidates and biologics (regulated by CBER) against potential agents of bioterrorism and emerging and re-emerging infectious diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Task V18: STUDY TO EVALUATE THE EFFICACY OF TOXIN IN ANIMAL MODEL
TASK V17: DEVELOPMENT OF ASSAYS AND REAGENTS FOR MONKEYPOX VACCINES
Task V12: CLINICAL SAMPLE TESTING FOR ZIKA VIRUS VACCINES
Task V17: CREATION OF INTERNATIONAL VIRUS STANDARDS
海外基金